Skip to main
XLAB

XLAB Market Capitalization Overview

Market Cap: $208.49M as of Aug 28, 2026

$208.49M
$21.10M (9.19%)past month
As of Aug 28, 2026, XLAB has a market capitalization of $208.49M. Over the past 30 days, its market cap has decreased by -56.31%, while in the last 12 months, it has decreased by -50.45%.

Market capitalization represents the total value of Exascale Labs Holdings Inc. as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

XLAB Market Cap Formula = Stock Price * Shares Outstanding

The market cap of XLAB helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

XLAB Market Cap History

DateMarket CapChange
Aug 3, 2026$185.37M-56.31%
Jul 1, 2026$424.28M-4.82%
Jun 1, 2026$445.78M+5.87%
May 1, 2026$421.07M+0.99%
Apr 1, 2026$416.95M+0.30%
Mar 2, 2026$415.71M-0.88%
Feb 2, 2026$419.42M-0.52%
Jan 2, 2026$421.60M+0.25%

XLAB End of Year Market Cap History

DateMarket CapChange
2026$208.49M-50.45%
2025$420.76M

FAQs About Exascale Labs Holdings Inc. (XLAB) Market Cap

As of Aug 28, 2026, the market capitalization of XLAB is $208.49M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Exascale Labs Holdings Inc.’s market capitalization has decreased by -9.19%, changing from $229.58M to $208.49M as of Aug 28, 2026.

In the last 3 months, Exascale Labs Holdings Inc.’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Exascale Labs Holdings Inc.’s market capitalization increased from – in January to $420.76M in December, reflecting a — change.

Exascale Labs Holdings Inc. (XLAB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.